Keenova's Strong Fourth Quarter Performance Reflects Brand Transition Success Keenova Therapeutics showcases impressive Q4 results, driven by strong sales in Acthar Gel and XIAFLEX, as the company transitions successfully into a branded therapeutics entity.

Keenova's Strong Fourth Quarter Performance Reflects Brand Transition Success #Ireland #Dublin #XIAFLEX #Acthar_Gel #Keenova

Keenova's Innovative Study on XIAFLEX® Addresses Dupuytren Contracture Recurrences Post-Surgery Keenova Therapeutics has published a significant study on XIAFLEX®, evaluating its efficacy in managing Dupuytren contracture recurrences. The research underscores the potential of non-surgical alternatives for patients.

Keenova's Innovative Study on XIAFLEX® Addresses Dupuytren Contracture Recurrences Post-Surgery #Ireland #Dublin #XIAFLEX #Dupuytren_Contracture #Keenova_Therapeutics

Keenova Achieves 100,000 Patients in Peyronie's Disease Treatment Milestone Keenova Therapeutics marks a significant achievement, with 100,000 patients prescribed XIAFLEX for Peyronie's disease, aiming to enhance awareness and diagnosis.

Keenova Achieves 100,000 Patients in Peyronie's Disease Treatment Milestone #Ireland #Dublin #Peyronie's_Disease #XIAFLEX #Keenova

Keenova's New Presentation Enhances Understanding of Dupuytren's Contracture Keenova Therapeutics is set to present new insights on Dupuytren's contracture at the AAHS Annual Meeting, focusing on patient perceptions and treatment experiences.

Keenova's New Presentation Enhances Understanding of Dupuytren's Contracture #Ireland #Dublin #XIAFLEX #Dupuytren's_Contracture #Keenova

Morning stretching and bending for Peyronie’s treatment. Woke up this morning in the middle of sprouting wood. It felt like someone was trying to rip my dick in half. I woke and was all “ABORT MISSION!”. Got it to stop getting hard. The RestoreX device doesn’t hurt, thankfully. #peyronies #xiaflex

Endo's Innovative Insights on Peyronie's Disease at AUA 2025 Annual Meeting At the AUA 2025 annual meeting, Endo presents groundbreaking findings on Peyronie's disease and treatment efficacy with XIAFLEX, offering new hope for patients.

Endo's Innovative Insights on Peyronie's Disease at AUA 2025 Annual Meeting #USA #Endo #Peyronie's_Disease #XIAFLEX #Malvern,_PA

Endo Makes Waves with New Research on Peyronie's Disease at SMSNA Annual Meeting Endo has announced nine insightful presentations on Peyronie's disease at the SMSNA Annual Meeting, showcasing innovative research on treatment options.

Endo Makes Waves with New Research on Peyronie's Disease at SMSNA Annual Meeting #United_States #Malvern #Endo #Peyronie's_Disease #XIAFLEX

Inaugural National Hand Health Month: Raising Awareness and Empowering Lives September marks the first National Hand Health Month, promoting awareness about hands' significance and conditions like Dupuytren's contracture.

Inaugural National Hand Health Month: Raising Awareness and Empowering Lives #XIAFLEX #Dupuytren's #National_Hand_Health

Fun fact: Ads for Peyronie's disease and Dupuytren's contracture came out at about the same time, and that's because a bent penis and a bent finger are treated with the same medication #xiaflex

Introducing the 'Prime Time' Campaign: A New Approach to Peyronie's Disease Awareness Endo's 'Prime Time' campaign raises awareness about Peyronie's Disease and promotes the use of XIAFLEX, aiming to empower men to seek treatment and support.

Introducing the 'Prime Time' Campaign: A New Approach to Peyronie's Disease Awareness #USA #Dublin #Peyronie's_Disease #XIAFLEX #Endo_Pharmaceuticals

a Xiaflex treatment in my right hand, as well as a grant to cover the hefty 20% copay. I’m so relieved as I’ve been drowning in despair as I haven’t been able to make art for nearly 4 years due to this miserable condition.
Yay for me and my hand! 🎉 🖐️
2/
#Dupuytrens #t1D #♿️ #Xiaflex

Endo, Inc. Reports First-Quarter 2025 Performance and Outlook for Future Growth Endo, Inc. shares its financial results for the first quarter of 2025, reaffirming its revenue guidance and discussing future growth strategies. XIAFLEX® shows promising performance.

Endo, Inc. Reports First-Quarter 2025 Performance and Outlook for Future Growth #United_States #Financial_Guidance #Endo #XIAFLEX #Malvern,_Pennsylvania

Endo's Innovative Spatial Computing Simulator Set to Transform Urology Training for Peyronie's Disease Treatment Endo, Inc. introduces advanced Spatial Computing Injection Simulator for urologists, enhancing training for Peyronie's disease treatment with digital and physical interaction.

Endo's Innovative Spatial Computing Simulator Set to Transform Urology Training for Peyronie's Disease Treatment #USA #Malvern #Endo #Peyronie's_Disease #XIAFLEX

Endo Introduces Groundbreaking Spatial Computing Simulator for Advanced Hand Specialist Training Endo, Inc. has launched a pioneering Spatial Computing Injection Simulator designed to enhance the learning experience for hand specialists by merging physical and digital training methods.

Endo Introduces Groundbreaking Spatial Computing Simulator for Advanced Hand Specialist Training #USA #Spatial_Computing #Malvern #Endo #XIAFLEX

Endo, Inc. Showcases Innovative Treatment for Dupuytren Contracture at IFSSH and IFSHT Congress Endo, Inc. presents critical data on Dupuytren contracture management with XIAFLEX at the upcoming IFSSH and IFSHT Congress, aiding patient care.

Endo, Inc. Showcases Innovative Treatment for Dupuytren Contracture at IFSSH and IFSHT Congress #USA #Endo #XIAFLEX #Malvern,_Pennsylvania #Dupuytren_Contracture

Endo to Present Peyronie's Disease Research Findings at AUA Annual Meeting Endo, Inc. reveals significant findings from a Phase 3 trial of XIAFLEX® for Peyronie's disease at the upcoming AUA meeting.

Endo to Present Peyronie's Disease Research Findings at AUA Annual Meeting #USA #Malvern #Endo #Peyronie's_Disease #XIAFLEX

Endo Introduces 'Steve's Journey': A Groundbreaking Ad for Dupuytren's Contracture Treatment with XIAFLEX® Endo, Inc. launches 'Steve’s Journey,' the first branded ad for XIAFLEX®. This campaign highlights real patient experiences.

Endo Introduces 'Steve's Journey': A Groundbreaking Ad for Dupuytren's Contracture Treatment with XIAFLEX® #United_States #Malvern #Endo #XIAFLEX #Dupuytren's